The development of personalised molecular therapeutics: A comparative ethnographic perspective on the use of genetic testing in ovarian cancer and col

该研究项目正在研究基因检测和个性化药物在晚期癌症患者治疗中的应用。过去，基因检测技术主要用于癌症预防领域。然而，近年来，随着在肿瘤学实践中个性化分子疗法的发展和交付取得进展，基因检测技术正在被整合到主流癌症治疗中。该研究项目将在一家大型三级NHS医院的卵巢癌和结直肠癌诊所进行。它将以临床人种学的方法为基础，与患者和医疗保健专业人员合作，在个性化医学发展的更广泛背景下探索基因检测的社会文化、政治和伦理影响。

The research project is examining the use of genetic testing and personalised medicine in the treatment of patients with advanced cancer. In the past genetic testing technologies have been primarily situated in the field of cancer prevention. Over recent years however, following advances made in the development and delivery of personalised molecular therapeutics in the practice of oncology, genetic testing technologies are being integrated into mainstream cancer care. This research project will be situated in an ovarian cancer and colorectal cancer clinic of a large tertiary NHS hospital. It will be grounded in the methods of clinical ethnography to engage with patients and healthcare professionals to explore the socio-cultural, political and ethical implications of genetic testing within the broader context of personalised medicine development.